Norges Bank’s Array Biopharma Inc ARRY Stock Holding History

Norges Bank’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2,066,511	Closed	-$95.7M	–	2147
2019 Q2	$95.7M	Hold	2,066,511	–	–	0.03%	531
2019 Q1	$50.4M	Buy	2,066,511 +123,452	+6%	+$2.57M	0.02%	865
2018 Q4	$27.7M	Hold	1,943,059	–	–	0.01%	1175
2018 Q3	$29.5M	Buy	1,943,059 +184,084	+10%	+$2.82M	0.01%	1270
2018 Q2	$29.5M	Hold	1,758,975	–	–	0.01%	1251
2018 Q1	$28.7M	Hold	1,758,975	–	–	0.01%	1195
2017 Q4	$22.5M	Hold	1,758,975	–	–	0.01%	1408
2017 Q3	$21.6M	Buy	1,758,975 +385,807	+28%	+$3.58M	0.01%	1392
2017 Q2	$11.5M	Buy	1,373,168 +761,830	+125%	+$6.23M	﹤0.01%	1683
2017 Q1	$5.46M	Buy	611,338 +561,338	+1,123%	+$5.97M	﹤0.01%	1870
2016 Q4	$440K	Hold	50,000	–	–	﹤0.01%	2122
2016 Q3	$322K	Buy	+50,000	New	+$193K	﹤0.01%	2128

Other funds holding ARRY

ASN

Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Norges Bank's ARRY Position: Q3 2019 in Review

Norges Bank sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 2,066,511 shares — an estimated $95.7M sold.

Norges Bank first reported a position in ARRY in Q3 2016 and held it in 12 quarters. The position peaked at $95.7M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

Norges Bank reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
Norges Bank sold 2,066,511 Array Biopharma Inc shares in Q3 2019, an estimated $95.7M.
Norges Bank first reported a position in Array Biopharma Inc in Q3 2016 and held it in 12 quarters.
Norges Bank's Array Biopharma Inc position peaked at $95.7M in Q2 2019.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Norges Bank's 13F filing for Q3 2019, filed 8 Nov 2019.